Mineralocorticoid Receptor
The mineralocorticoid receptor is a nuclear hormone receptor for aldosterone and glucocorticoids. It acts as a transcription factor to regulate the water-salt homeostasis and blood pressure in the target cell. It also plays physiological roles in kidney, brain and cardiovascular system.
Products Related to Mineralocorticoid Receptor(23)
- GC15831EplerenoneCAS: 107724-20-9Purity: >98.00%
Eplerenone is an orally active mineralocorticoid receptor (MR) antagonist that blocks the effects of aldosterone, with an IC 50 value of 0.081μM.
- GC17090RU 28318, potassium saltCAS: 76676-34-1Purity: >98.00%
RU 28318, potassium salt is a potent mineralocorticoid (MR) antagonist.
- GC19143EsaxerenoneCAS: 1632006-28-0Purity: >99.50%
Esaxerenone (CS-3150), a selective nonsteroidal mineralocorticoid receptor antagonist, has been shown to bind to mineralocorticoid receptors, thereby inhibiting aldosterone binding and activation of the receptor.
- GC19273OsilodrostatCAS: 928134-65-0Purity: >99.50%
Osilodrostat (LCI699) is a potent inhibitor of human 11β-hydroxylase and aldosterone synthase with IC50 values of 2.5 and 0.7 nM, respectively.
- GC31448Apararenone (MT-3995)CAS: 945966-46-1Purity: >98.50%
Apararenone (MT-3995) (MT-3995) is a novel non-steroidal mineralocorticoid receptor antagonists under development for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis.
- GC31789Fludrocortisone (9α-Fludrocortisone)CAS: 127-31-1Purity: >95.00%
Fludrocortisone (9α-Fludrocortisone), a synthetic mineralocorticoid with anti-inflammatory activity.
- GC33848Fludrocortisone acetate (9α-Fludrocortisone acetate)CAS: 514-36-3Purity: >99.50%
Fludrocortisone acetate (9α-Fludrocortisone acetate) (9α-Fludrocortisone acetate (9α-Fludrocortisone acetate)) is a synthetic mineralocorticoid, used to control the amount of sodium and fluids in your body.
- GC35862DicirenoneCAS: 41020-79-5Purity: >98%
Dicirenone (SC26304) inhibits the effects of Aldosterone on urinary K+:Na+ ratios and the binding of [3H]Aldosterone to renal cytoplasmic and nuclear receptors.
- GC39564VamoroloneCAS: 13209-41-1Purity: >99.00%
Vamorolone (VBP15) is a first-in-class, orally active dissociative steroidal anti-inflammatory drug and membrane-stabilizer.
- GC62332(Rac)-FinerenoneCAS: 1050477-27-4Purity: >98%
(Rac)-Finerenone ((Rac)-BAY 94-8862) is the racemate of Finerenone.
- GC6275918-OxocortisolCAS: 2410-60-8Purity: >98.00%
18-Oxocortisol is a derivative of cortisol that is produced by aldosterone synthase (CYP11B2).
- GC64593BaxdrostatCAS: 1428652-17-8Purity: >98.00%
Baxdrostat is a novel, orally active aldosterone synthase (CYP11B2) inhibitor.
- GC64594(S)-BaxdrostatCAS: 1428652-16-7Purity: >98.00%
(S)-Baxdrostat is the S-enantiomer of Baxdrostat.
- GC66454Osilodrostat phosphateCAS: 1315449-72-9Purity: >99.00%
Osilodrostat (LCI699) phosphate is a potent, orally active11β-hydroxylase (CYP11B1) inhibitor with an IC50 value of 35 nM. Osilodrostat phosphate is a potent, orally aldosterone synthase (CYP11B2) inhibitor with IC50 values of 0.7 nM and 160 nM for human aldosterone synthase and rat aldosterone synthase, respectively. Osilodrostat phosphate inhibits aldosterone and corticosterone synthesis. Osilodrostat phosphate has blood pressure lowering ability. Osilodrostat phosphate can be used for research of Cushing syndrome (CS).
- GC69397LorundrostatCAS: 1820940-17-7Purity: >99.00%
Lorundrostat is an aldosterone synthase inhibitor.
- GC80845Spironolactone-d 6 -1Purity: >99.00%
Spironolactone -d 6 -1 is the deuterium labeled Spironolactone.
- GC80862(R)-FinerenoneCAS: 1050477-30-9Purity: >99.50%
(R)-Finerenone ((R)-BAY 94-8862) is the R-isomer of Finerenone.
- GC80863(R)-BalcinrenoneCAS: 1850385-65-7Purity: >99.50%
(R)-Balcinrenone ((R)-AZD9977) is an isomer of Balcinrenone.
- GC80864Esaxerenone-d 4Purity: >98%
Esaxerenone -d 4 (CS-3150-d 4 ) is the deuterium labeled Esaxerenone.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC15831 | Eplerenone | 107724-20-9 | >98.00% | |
Eplerenone is an orally active mineralocorticoid receptor (MR) antagonist that blocks the effects of aldosterone, with an IC 50 value of 0.081μM. | ||||
| GC12349 | Deoxycorticosterone acetate | 56-47-3 | >98.00% | |
Steroid hormone | ||||
| GC17090 | RU 28318, potassium salt | 76676-34-1 | >98.00% | |
RU 28318, potassium salt is a potent mineralocorticoid (MR) antagonist. | ||||
| GC17537 | Canrenone | 976-71-6 | >98.00% | |
Mineralocorticoid receptor antagonist | ||||
| GC19143 | Esaxerenone | 1632006-28-0 | >99.50% | |
Esaxerenone (CS-3150), a selective nonsteroidal mineralocorticoid receptor antagonist, has been shown to bind to mineralocorticoid receptors, thereby inhibiting aldosterone binding and activation of the receptor. | ||||
| GC19273 | Osilodrostat | 928134-65-0 | >99.50% | |
Osilodrostat (LCI699) is a potent inhibitor of human 11β-hydroxylase and aldosterone synthase with IC50 values of 2.5 and 0.7 nM, respectively. | ||||
| GC31448 | Apararenone (MT-3995) | 945966-46-1 | >98.50% | |
Apararenone (MT-3995) (MT-3995) is a novel non-steroidal mineralocorticoid receptor antagonists under development for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis. | ||||
| GC31789 | Fludrocortisone (9α-Fludrocortisone) | 127-31-1 | >95.00% | |
Fludrocortisone (9α-Fludrocortisone), a synthetic mineralocorticoid with anti-inflammatory activity. | ||||
| GC33848 | Fludrocortisone acetate (9α-Fludrocortisone acetate) | 514-36-3 | >99.50% | |
Fludrocortisone acetate (9α-Fludrocortisone acetate) (9α-Fludrocortisone acetate (9α-Fludrocortisone acetate)) is a synthetic mineralocorticoid, used to control the amount of sodium and fluids in your body. | ||||
| GC35862 | Dicirenone | 41020-79-5 | >98% | |
Dicirenone (SC26304) inhibits the effects of Aldosterone on urinary K+:Na+ ratios and the binding of [3H]Aldosterone to renal cytoplasmic and nuclear receptors. | ||||
| GC39564 | Vamorolone | 13209-41-1 | >99.00% | |
Vamorolone (VBP15) is a first-in-class, orally active dissociative steroidal anti-inflammatory drug and membrane-stabilizer. | ||||
| GC62332 | (Rac)-Finerenone | 1050477-27-4 | >98% | |
(Rac)-Finerenone ((Rac)-BAY 94-8862) is the racemate of Finerenone. | ||||
| GC62386 | AZD9977 | 1850385-64-6 | >99.50% | |
AZD9977 is a potent, selective, and orally active mineralocorticoid receptor (MR) modulator. | ||||
| GC62759 | 18-Oxocortisol | 2410-60-8 | >98.00% | |
18-Oxocortisol is a derivative of cortisol that is produced by aldosterone synthase (CYP11B2). | ||||
| GC64593 | Baxdrostat | 1428652-17-8 | >98.00% | |
Baxdrostat is a novel, orally active aldosterone synthase (CYP11B2) inhibitor. | ||||
| GC64594 | (S)-Baxdrostat | 1428652-16-7 | >98.00% | |
(S)-Baxdrostat is the S-enantiomer of Baxdrostat. | ||||
| GC65465 | Ocedurenone | 1359969-24-6 | >98% | |
Ocedurenone is a corticosteroid receptor antagonist. | ||||
| GC66454 | Osilodrostat phosphate | 1315449-72-9 | >99.00% | |
Osilodrostat (LCI699) phosphate is a potent, orally active11β-hydroxylase (CYP11B1) inhibitor with an IC50 value of 35 nM. Osilodrostat phosphate is a potent, orally aldosterone synthase (CYP11B2) inhibitor with IC50 values of 0.7 nM and 160 nM for human aldosterone synthase and rat aldosterone synthase, respectively. Osilodrostat phosphate inhibits aldosterone and corticosterone synthesis. Osilodrostat phosphate has blood pressure lowering ability. Osilodrostat phosphate can be used for research of Cushing syndrome (CS). | ||||
| GC69397 | Lorundrostat | 1820940-17-7 | >99.00% | |
Lorundrostat is an aldosterone synthase inhibitor. | ||||
| GC80845 | Spironolactone-d 6 -1 | - | >99.00% | |
Spironolactone -d 6 -1 is the deuterium labeled Spironolactone. | ||||
| GC80862 | (R)-Finerenone | 1050477-30-9 | >99.50% | |
(R)-Finerenone ((R)-BAY 94-8862) is the R-isomer of Finerenone. | ||||
| GC80863 | (R)-Balcinrenone | 1850385-65-7 | >99.50% | |
(R)-Balcinrenone ((R)-AZD9977) is an isomer of Balcinrenone. | ||||
| GC80864 | Esaxerenone-d 4 | - | >98% | |
Esaxerenone -d 4 (CS-3150-d 4 ) is the deuterium labeled Esaxerenone. | ||||
